Overview

CYT003-QbG10 for Treatment of Allergic Asthma Bronchial

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test whether treatment with CYT003-QbG10 can improve asthma symptoms in patients with allergic bronchial asthma. The active treatment will be compared against placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Cytos Biotechnology AG